Search

everythinglearnresearchcommunity

for

Search:↓

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Menopause affects hair and skin; more research needed for treatment.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Minoxidil effectively treats female pattern hair loss.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.